Asterias Biotherapeutics, Inc. Contracts & Agreements

Sublease Agreement between the Company and Novo Nordisk Research Center Seattle, Inc (Filed With SEC on November 9, 2018)

Agreement and Plan of Merger dated November 7, 2018, among BioTime, Inc., Patrick Merger Sub, Inc. and Asterias Biotherapeutics, Inc (Filed With SEC on November 8, 2018)

Amended and Restated Employment Agreement, dated as of November 7, 2018, by and between Asterias Biotherapeutics, Inc. and Craig Halberstadt (Filed With SEC on November 8, 2018)

Amended and Restated Employment Agreement, dated as of November 7, 2018, by and between Asterias Biotherapeutics, Inc. and Edward Wirth, III (Filed With SEC on November 8, 2018)

Amended and Restated Employment Agreement, dated as of November 7, 2018, by and between Asterias Biotherapeutics, Inc. and Ryan Chavez (Filed With SEC on November 8, 2018)

Amendment to Securities Purchase Agreement (Filed With SEC on November 14, 2017)

Form of Securities Purchase Agreement, dated October 16, 2017, by and between the Company and the Investors named thereto (Filed With SEC on October 16, 2017)

2Placement Agent Agreement, dated October 15, 2017, by and between the Company and Chardan Capital Markets, LLC (Filed With SEC on October 16, 2017)

Employment Agreement, by and between the Company and Michael Mulroy (Filed With SEC on May 23, 2017)

Separation Agreement, by and between the Company and Steve Cartt (Filed With SEC on May 23, 2017)

Amendment to the At the Market Sales Agreement, dated March 28, 2017, by and between the Company, MLV & Co. and FBR Capital Markets & Co (Filed With SEC on March 28, 2017)

Employment Agreement of Ryan D. Chavez, dated July 18, 2016 (Filed With SEC on November 17, 2016)

Development and Manufacturing Services Agreement, dated August 3, 2016, between Asterias and Cognate BioServices, Inc (Filed With SEC on November 14, 2016)

Amended and restated 2013 Equity Incentive Plan (Filed With SEC on August 15, 2016)

Underwriting Agreement, dated May 10, 2016 by and between the Company and Raymond James & Associates, Inc (Filed With SEC on May 10, 2016)

Form of Warrant Agreement by and between the Company and American Stock Transfer & Trust Company, including the form of Warrant (Filed With SEC on May 10, 2016)

Employment Agreement dated November 2, 2015 between Georgia Erbez and Asterias Biotherapeutics, Inc (Filed With SEC on March 29, 2016)

Employment Agreement dated February 28, 2016 between Stephen L. Cartt and Asterias Biotherapeutics, Inc (Filed With SEC on March 29, 2016)

Separation Agreement, as of March 10, 2016, between Pedro Lichtinger and Asterias Biotherapeutics, Inc (Filed With SEC on March 29, 2016)

Amendment to the Notice of Award from the California Institute of Regenerative Medicine dated March 2, 2016 (Filed With SEC on March 29, 2016)

Separation Agreement, as of March 21, 2016, between Georgia Erbez and Asterias Biotherapeutics, Inc (Filed With SEC on March 29, 2016)

Cross License Agreement between Asterias, BioTime and ES Cell International Pte Ltd (Filed With SEC on February 18, 2016)

Share Transfer Agreement between Asterias and BioTime (Filed With SEC on February 18, 2016)

Services Agreement, dated October 8, 2015 by the Company and Catapult (Filed With SEC on October 15, 2015)

Employment Agreement with Edward D. Wirth III, dated June 16, 2013 (Filed With SEC on August 10, 2015)

At the Market Issuance Sales Agreement, dated April 10, 2015, by and between the Registrant and MLV & Co. LLC (Filed With SEC on April 10, 2015)

Form of Subscription Agreement 2015 Private Placement (Filed With SEC on March 11, 2015)

Notice of Grant Award, dated as of October 14, 2014, between the California Institute for Regenerative Medicine and Asterias Biotherapeutics, Inc (Filed With SEC on March 11, 2015)

Amendment to Notice of Grant Award, dated as of November 26, 2014, between the California Institute for Regenerative Medicine and Asterias Biotherapeutics, Inc (Filed With SEC on March 11, 2015)

Underwriting Agreement, dated February 5, 2015 by and between the Company and MLV & Co. LLC (Filed With SEC on February 6, 2015)

Lease, dated December 30, 2013, by and between BMR 6300 Dumbarton Circle, LP, and Asterias Biotherapeutics, Inc (Filed With SEC on March 17, 2014)

Form of Underwriters Warrant (Filed With SEC on November 27, 2013)

Warrant Agreement Dated as of October 1, 2013 (Filed With SEC on October 1, 2013)

Specimen of Series A Common Stock Certificate (Filed With SEC on September 3, 2013)

2013 Equity Incentive Plan (Filed With SEC on June 26, 2013)

Form of Warrant Agreement (Filed With SEC on April 3, 2013)

Stock and Warrant Purchase Agreement, dated January 4, 2013, between BioTime Acquisition Corporation and Romulus Films Ltd (Filed With SEC on April 3, 2013)

Sublease dated April 1, 2013 between BioTime, Inc. and BioTime Acquisition Corporation (Filed With SEC on April 3, 2013)

Shared Facilities and Services Agreement, dated April 1, 2013, between Asterias Biotherapeutics, Inc. and BioTime, Inc (Filed With SEC on April 3, 2013)

2013 Equity Incentive Plan (Filed With SEC on April 3, 2013)

Promissory Note, dated April 1, 2013, payable to BioTime, Inc (Filed With SEC on April 3, 2013)

Category

Industry

Companies

Contracts

Asterias Biotherapeutics, Inc. Contracts & Agreements